The PromarkerD clinical validation study results were presented at the Australian Diabetes Society (ADS)/Australian Diabetes Educators Association (ADEA) Annual Scientific Meeting held between 30 August – 1 September 2017, in Perth, Western Australia.

The presentation was titled ‘Validation of Models for Predicting Rapidly Declining Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II’.